sproxil

E-Team Sproxil featured in Business Week

Sproxil, a 2007 NCIIA E-Team grantee developing cellphone technology to combat the use of counterfeit drugs in Nigeria and Ghana, was recently featured in Business Week online. Read the story.

Previously, Sproxil had been awarded $10,000 by the Clinton Global Initiative University. Ashifi Gogo, Sproxil's lead technologist, also received an oustanding commitment award.

 

E-Teams in the news


 

NCIIA-funded E-Teams keep making the news!

Miss the 2010 March Madness for the Mind showcase of student innovation in San Francisco? You can see the teams in this Voice of America video.

Former E-Team Sproxil is making progress in the fight against fake drugs in Nigeria. Read the story on Discovery.com.

Want to advance your student team? Apply for E-Team funding now! Grants of up to $20,000 are available. Deadline, May 7.

More success for Sproxil, the anti-counterfeit drug technology company

Sproxil, a 2007 NCIIA E-Team grantee developing cellphone technology to combat the use of counterfeit drugs in Nigeria and Ghana, has been awarded $10,000 by the Clinton Global Initiative University. Ashifi Gogo, Sproxil's lead technologist, also received an oustanding commitment award.

Ashifi is being granted $10,000 towards materials to create the item-unique coding for one million drug labels and to offset the costs of SMS texts for consumers.

Read about the award, including an interview with Ashifi, here.

Sproxil

Dartmouth College, 2007 - $18,466

According to the World Health Organization, 25% of the medicines sold in the developing world are inauthentic copies containing little or no active ingredients. When fake drugs are laced with lethal ingredients they can lead to mass fatalities, as was the case in a 1995 outbreak of false meningitis vaccine in Niger that killed 195,00 people. To fight the problem, this E-Team is developing an SMS protocol called UPAP. UPAP is a labeling system for drug manufacturers that allows customers to use their cell phones to text message covert, one-time alphanumeric codes to the drug company's back-end database for verification. The system verifies whether or not the drug is genuine, allowing the customer to get information on what they're buying right at the pharmacy.

A number of competing drug-verification technologies exist, such as RFID and colorimetric/holographic signatures, but none combine UPAP's low cost and high effectiveness. The team plans to focus initially on Ghana, where 40% of the drugs are counterfeit.

Update: a member of the original team has incorporated the venture as Sproxil, which has several partners, including the World Economic Forum Technology Pioneers Program, Ashoka, Nokia, and a number of telecoms carriers and pharmaceutical regulators in Ghana, Nigeria, and India.

Syndicate content